ESC TV Today – Your Cardiovascular News

European Society of Cardiology

The European Society of Cardiology brings you the most relevant news in cardiovascular medicine, opinions from leading experts, and insight into the latest developments in our field that really matter. You can also be interested in other ESC podcasts: ESC Cardio Talk, EHRA Cardio Talk and HFA Cardio Talk. Check them out!

Start Here
Episode 5: Among the topics: Iron deficiency in heart failure – Cardiovascular management of patients undergoing non-cardiac surgery
3d ago
Episode 5: Among the topics: Iron deficiency in heart failure – Cardiovascular management of patients undergoing non-cardiac surgery
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studiesThe IRONMAN trial and the role of iron deficiency in heart failureNew ESC Guidelines on cardiovascular management of patients undergoing non-cardiac surgeryStatistics Made Easy: Part I Host: Rick Grobbee Guests: Sigrun Halvorsen, Paul Kalra and Emma Svennberg Want to watch that episode? Go to:   Disclaimer This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Stephan Achenbach, Rick Grobbee, Sigrun Halvorsen and Nicolle Kraenkel declared to have no potential conflict of interest to report. Carlos Aguiar declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Giuseppe Biondi-Zoccai declared to have potential conflicts of interest to report: Giuseppe Biondi-Zoccai has consulted for Balmed, Cardionovum, Crannmedical, Eukon, Innovheart, Guidotti, Meditrial, Microport, Opsens Medical, Replycare, Teleflex, and Terumo. Davide Capodanno declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi. Paul Kalra declared to have potential conflicts of interest to report: Research grants: Pharmacosmos. Consultancy and lectures honoraria: Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, Pfizer, Pharmacosmos, Servier, Vifor Pharma . Emma Svennberg declared to have potential conflicts of interest to report: Institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme
Episode 5: Among the topics: Iron deficiency in heart failure – Cardiovascular management of patients undergoing non-cardiac surgery
3d ago
Episode 5: Among the topics: Iron deficiency in heart failure – Cardiovascular management of patients undergoing non-cardiac surgery
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studiesThe IRONMAN trial and the role of iron deficiency in heart failureNew ESC Guidelines on cardiovascular management of patients undergoing non-cardiac surgeryStatistics Made Easy: Part I Host: Rick Grobbee Guests: Sigrun Halvorsen, Paul Kalra and Emma Svennberg Want to watch that episode? Go to:   Disclaimer This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Stephan Achenbach, Rick Grobbee, Sigrun Halvorsen and Nicolle Kraenkel declared to have no potential conflict of interest to report. Carlos Aguiar declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Giuseppe Biondi-Zoccai declared to have potential conflicts of interest to report: Giuseppe Biondi-Zoccai has consulted for Balmed, Cardionovum, Crannmedical, Eukon, Innovheart, Guidotti, Meditrial, Microport, Opsens Medical, Replycare, Teleflex, and Terumo. Davide Capodanno declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi. Paul Kalra declared to have potential conflicts of interest to report: Research grants: Pharmacosmos. Consultancy and lectures honoraria: Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, Pfizer, Pharmacosmos, Servier, Vifor Pharma . Emma Svennberg declared to have potential conflicts of interest to report: Institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme
Episode 4: Highlights of the ESC cardio-oncology guidelines - New data in renal denervation: SYMPLICITY HTN-3
Nov 10 2022
Episode 4: Highlights of the ESC cardio-oncology guidelines - New data in renal denervation: SYMPLICITY HTN-3
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent trialsHighlights of the ESC Cardio Oncology GuidelinesNew Data in Renal Denervation: SYMPLICITY HTN-3Mythbusters: Coffee increases the risk for heart disease Host: Rick Grobbee Guests: Carlos Aguiar, Teresa Lopez Fernandez and Deepak Bhatt Want to watch that episode? Go to: Disclaimer: This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Stephan Achenbach, Rick Grobbee, Nicolle Kraenkel and Teresa Lopez Fernandez declared to have no potential conflict of interest to report. Carlos Aguiar declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Deepak Bhatt declared to have potential conflicts of interest to report: Research funding from Medtronic paid to Brigham and Women’s hospital for my role as co-Principal Investigator of SYMPLICITY HTN-3. Davide Capodanno declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi. Emma Svennberg declared to have potential conflicts of interest to report: Institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme
Episode 3: Factor XIa Inhibitors: A Breakthrough in Anticoagulation? - Heart Failure Treatment: New Concepts for 2023 and Beyond
Oct 27 2022
Episode 3: Factor XIa Inhibitors: A Breakthrough in Anticoagulation? - Heart Failure Treatment: New Concepts for 2023 and Beyond
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode tackles: Cardiology this WeekFactor XIa Inhibitors: A Breakthrough in Anticoagulation?Heart Failure Treatment: New Concepts for 2023 and BeyondSnapshots Host: Susanna Price Guests: Carlos Aguiar, Robert Storey, Carolyn Lam and Stephan Achenbach Want to watch that episode? Go to: Disclaimer: This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests Stephan Achenbach, Nicolle Kraenkel, Susanna Price and Robert Storey declared to have no potential conflict of interest to report. Carlos Aguiar declared to have potential conflict of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Davide Capodanno declared to have potential conflict of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi. Carolyn Lam declared to have potential conflict of interest to report: Carolyn S.P. Lam is supported by a Clinician Scientist Award from the National Medical Research Council of Singapore; has received research support from Bayer and Roche Diagnostics; has served as consultant or on the Advisory Board/ Steering Committee/ Executive Committee for Actelion, Alleviant Medical, Allysta Pharma, Amgen, AnaCardio AB, Applied Therapeutics, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Cytokinetics, Darma Inc., EchoNous Inc, Eli Lilly, Impulse Dynamics, Intellia Therapeutics, Ionis Pharmaceutical, Janssen Research & Development LLC, Medscape/WebMD Global LLC, Merck, Novartis, Novo Nordisk, Prosciento Inc, Radcliffe Group Ltd., ReCor Medical, Roche Diagnostics, Sanofi, Siemens Healthcare Diagnostics and Us2.ai; and serves as co-founder & non-executive director of Us2.ai. Emma Svennberg declared to have potential conflict of interest to report: Institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme